Click to Share
 

Report: Tissue Engineering, Cell Therapy and Transplantation Worldwide 2009-2018

This report examines the status of technologies, applications and markets for tissue engineering, cell therapy and transplantation. The report provides company market share, and forecast to 2018, for the U.S., Europe, Asia/Pacific and Rest of World.

Manufacturer - MedMarket Diligence, LLC
Model # - S520
SKU - S520
Submitted By - MedMarket Diligence, LLC (Owner)
Country - United States
Category - Market Research

Contact   |   Link To Product   |   More Products By This Company

Specifications

Companies profiled :   147
Pages :   312
Number of exhibits :   74
Price :   $3,450.00
Publication date :   February 2010

Details

This report examines the status of technologies, applications and markets for tissue engineering, cell therapy and tissue/cell transplantation. The report reviews therapeutic tissue engineering, tissue reconstruction, cell therapies, tissue/organ transplantation and related technologies under various stages of development at nearly 150 companies. The report details the technology development, projected market introduction dates and/or current and forecast market size and competitor shares for products being developed to address major causes of death and disease spanning applications in cardiovascular, neurological, orthopaedic, urological, skin, dental, ophthalmological, gastrointestinal, organ transplant, cancer and others. The report details the status of product development and assesses the current and forecast worldwide market for tissue engineering, cell therapy and transplantation.

The report provides market size and share data, with forecast market data to 2018, for the U.S., Europe, Asia/Pacific and Rest of World.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Table of Contents
Executive Summary
SECTION 1: TISSUE ENGINEERING AND CELL THERAPY INDUSTRY BACKGROUND
SECTION 2: CLINICAL DISORDERS AND THERAPY NEEDS
SECTION 3: PRODUCT & COMPANY-SPONSORED TECHNOLOGY DEVELOPMENTS (APPROVED AND IN DEVELOPMENT)
SECTION 4: MARKETS, POTENTIAL MARKETS, AND COMPETITOR SHARES
SECTION 5: COMPANY PROFILES

Tags

, ,


Disclaimer: Submitters of product listings are solely responsible for their content. PRLog can't be held liable for the contents of the product listings.   Report Abuse


Like PRLog?
9K2K1K
Click to Share